Omega Healthcare Investors, Inc. (NYSE:OHI) Receives Consensus Recommendation of “Moderate Buy” from Analysts

Shares of Omega Healthcare Investors, Inc. (NYSE:OHIGet Free Report) have been given a consensus rating of “Moderate Buy” by the ten ratings firms that are currently covering the stock, Marketbeat Ratings reports. Five analysts have rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average 1-year price objective among brokers that have issued ratings on the stock in the last year is $41.67.

A number of research analysts have commented on the company. JMP Securities restated a “market perform” rating on shares of Omega Healthcare Investors in a research note on Friday, February 7th. Mizuho upped their price target on Omega Healthcare Investors from $35.00 to $37.00 and gave the stock a “neutral” rating in a research note on Thursday, December 5th. BMO Capital Markets upgraded Omega Healthcare Investors from a “market perform” rating to an “outperform” rating and set a $45.00 price target on the stock in a research note on Monday, December 9th. BNP Paribas raised Omega Healthcare Investors from a “neutral” rating to an “outperform” rating and set a $49.00 price objective on the stock in a research report on Thursday, October 31st. Finally, Royal Bank of Canada upped their price objective on Omega Healthcare Investors from $39.00 to $43.00 and gave the stock a “sector perform” rating in a research report on Monday, November 11th.

Read Our Latest Analysis on OHI

Omega Healthcare Investors Stock Down 1.4 %

NYSE:OHI opened at $35.68 on Monday. The company has a quick ratio of 7.07, a current ratio of 7.07 and a debt-to-equity ratio of 1.02. The stock’s fifty day moving average is $37.45 and its two-hundred day moving average is $39.05. Omega Healthcare Investors has a 52 week low of $29.66 and a 52 week high of $44.42. The stock has a market capitalization of $10.05 billion, a price-to-earnings ratio of 23.02, a price-to-earnings-growth ratio of 1.09 and a beta of 0.99.

Omega Healthcare Investors (NYSE:OHIGet Free Report) last released its quarterly earnings results on Wednesday, February 5th. The real estate investment trust reported $0.74 EPS for the quarter, topping analysts’ consensus estimates of $0.41 by $0.33. Omega Healthcare Investors had a return on equity of 9.71% and a net margin of 38.65%. Research analysts anticipate that Omega Healthcare Investors will post 2.86 EPS for the current year.

Omega Healthcare Investors Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, February 18th. Stockholders of record on Monday, February 10th were given a dividend of $0.67 per share. This represents a $2.68 dividend on an annualized basis and a dividend yield of 7.51%. The ex-dividend date of this dividend was Monday, February 10th. Omega Healthcare Investors’s dividend payout ratio is currently 172.90%.

Hedge Funds Weigh In On Omega Healthcare Investors

Several large investors have recently bought and sold shares of the business. GF Fund Management CO. LTD. purchased a new position in Omega Healthcare Investors in the fourth quarter valued at $177,000. Public Employees Retirement System of Ohio increased its holdings in Omega Healthcare Investors by 3.5% in the fourth quarter. Public Employees Retirement System of Ohio now owns 483,385 shares of the real estate investment trust’s stock valued at $18,296,000 after buying an additional 16,187 shares during the last quarter. Novem Group purchased a new position in Omega Healthcare Investors in the fourth quarter valued at $493,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its holdings in Omega Healthcare Investors by 10.6% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,837,732 shares of the real estate investment trust’s stock valued at $69,558,000 after buying an additional 175,768 shares during the last quarter. Finally, Voloridge Investment Management LLC increased its holdings in Omega Healthcare Investors by 128.2% in the fourth quarter. Voloridge Investment Management LLC now owns 515,109 shares of the real estate investment trust’s stock valued at $19,497,000 after buying an additional 289,402 shares during the last quarter. Hedge funds and other institutional investors own 65.25% of the company’s stock.

Omega Healthcare Investors Company Profile

(Get Free Report

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.

Featured Articles

Analyst Recommendations for Omega Healthcare Investors (NYSE:OHI)

Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.